The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

Non-transfusion-dependent thalassemia encompasses three clinically distinct forms -- beta-thalassaemia intermedia, hemoglobin E/beta-thalassaemia (mild and moderate forms), and al ...

Tharu tribals face higher rates of thalassemia (22-24%) and sickle cell anaemia (60%) than the general population, prompting a medical camp for 2 lakh people.